On 26 July, James J. Collins and Richard Lee will be discussing the use of Synthetic biology and interdisciplinary approaches for antibiotic discovery.

In this webinar, the speakers will discuss will provide an overview of basic animal models and explain the basis for their selection and limitations for specific situations and needs to study the activity of antibiotics. The speakers will give the following presentations: - Overview of common animal models (Lynn Miesel) - Zebrafish larvae as an […]

On 23 August, Michael N. Dudley and Glenn Dale will discuss the Challenges and options in developing antibiotic combinations.

Since 2015, the World Antimicrobial Resistance Congress has attracted top thought leaders, hospitals, companies, and policymakers as the annual, go-to event in the Antimicrobial Resistance (AMR) space. We have grown into the most impactful event in advancing solutions to combat this pressing global health crisis. Diagnostic developers, antibiotic biotechs & pharmaceutical companies, stewardship technologies, access […]

The EMBO Workshop on Tuberculosis 2022, originally planned for September 2020 and postponed to 2022 due to the Covid-19 pandemic, has recently received again the support from EMBO, and is now scheduled to be held from September 12-16, 2022 at the Conference Centre (CIS) of the Institut Pasteur in Paris. The EMBO Workshop on Tuberculosis 2022 will be […]

Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements […]